rs241447
From SNPedia
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (A;A) | 0 | common in clinvar |
| Make rs241447(A;G) |
| Make rs241447(G;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 6 |
| Position | 32828974 |
| Gene | TAP2 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs241447 |
| dbSNP (classic) | rs241447 |
| ClinGen | rs241447 |
| ebi | rs241447 |
| HLI | rs241447 |
| Exac | rs241447 |
| Gnomad | rs241447 |
| Varsome | rs241447 |
| LitVar | rs241447 |
| Map | rs241447 |
| PheGenI | rs241447 |
| Biobank | rs241447 |
| 1000 genomes | rs241447 |
| hgdp | rs241447 |
| ensembl | rs241447 |
| geneview | rs241447 |
| scholar | rs241447 |
| rs241447 | |
| pharmgkb | rs241447 |
| gwascentral | rs241447 |
| openSNP | rs241447 |
| 23andMe | rs241447 |
| SNPshot | rs241447 |
| SNPdbe | rs241447 |
| MSV3d | rs241447 |
| GWAS Ctlg | rs241447 |
| Merged from | Rs111033561 |
| GMAF | 0.2842 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
| ClinVar | |
|---|---|
| Risk | rs241447(G;G) |
| Alt | rs241447(G;G) |
| Reference | Rs241447(A;A) |
| Significance | Non-pathogenic |
| Disease | PEPTIDE TRANSPORTER PSF2 POLYMORPHISM not specified |
| Variation | info |
| Gene | TAP2 |
| CLNDBN | PEPTIDE TRANSPORTER PSF2 POLYMORPHISM not specified |
| Reversed | 1 |
| HGVS | NC_000006.11:g.32796751T\x3d; NC_000006.11:g.32796751T>C |
| CLNSRC | OMIM Allelic Variant |
| CLNACC | RCV000014728.2, RCV000455618.1, |
[PMID 17192492] Genetic control of alternative splicing in the TAP2 gene: possible implication in the genetics of type 1 diabetes.
[PMID 17708757
] Genome bioinformatic analysis of nonsynonymous SNPs.
[PMID 19387463
] Variation in the ATP-binding cassette transporter 2 gene is a separate risk factor for systemic lupus erythematosus within the MHC.
[PMID 22911334
] A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region
[PMID 23395648] Genetic evidence of TAP1 gene variant as a susceptibility factor in Indian leprosy patients.
